Lucinda Y. Quan

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Lucinda Y. Quan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lucinda Y. Quan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. Executive Vice President, Chief Business Officer and General Counsel Stock Option (Right to Buy) 48,000 08 Sep 2023 Direct

Insider Reports Filed by Lucinda Y. Quan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALGS Aligos Therapeutics, Inc. 08 Sep 2023 1 $0 4 Executive Vice President, Chief Business Officer and General Counsel 12 Sep 2023, 16:07
ALGS Aligos Therapeutics, Inc. 15 Mar 2023 1 $0 4 Executive Vice President, Chief Business Officer and General Counsel 17 Mar 2023, 16:10
ALGS Aligos Therapeutics, Inc. 07 Jul 2022 1 $0 4 Executive Vice President, Chief Business Officer and General Counsel 11 Jul 2022, 16:15
ALGS Aligos Therapeutics, Inc. 04 Feb 2022 2 $0 4 Executive Vice President, Chief Business Officer and General Counsel 08 Feb 2022, 15:07